Patrick Roger

1.2k total citations
16 papers, 856 citations indexed

About

Patrick Roger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Patrick Roger has authored 16 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Patrick Roger's work include Pituitary Gland Disorders and Treatments (8 papers), Adrenal Hormones and Disorders (6 papers) and Hormonal Regulation and Hypertension (5 papers). Patrick Roger is often cited by papers focused on Pituitary Gland Disorders and Treatments (8 papers), Adrenal Hormones and Disorders (6 papers) and Hormonal Regulation and Hypertension (5 papers). Patrick Roger collaborates with scholars based in France, Italy and Morocco. Patrick Roger's co-authors include Antoine Tabarin, Martine Duclos, Bogdan Catargi, Pascal Barat, V. Vergnot, H. Gin, Vincent Rigalleau, Jérôme Berge, Blandine Gatta and F Leprat and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Fertility and Sterility and Clinical Endocrinology.

In The Last Decade

Patrick Roger

16 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Roger France 12 663 315 108 103 98 16 856
Wojciech Jeske Poland 16 567 0.9× 320 1.0× 71 0.7× 38 0.4× 66 0.7× 64 828
Monica De Leo Italy 16 1.3k 2.0× 605 1.9× 108 1.0× 84 0.8× 82 0.8× 20 1.5k
Aurora Aragón Alonso United Kingdom 10 561 0.8× 328 1.0× 157 1.5× 113 1.1× 23 0.2× 13 815
P. T. Pullan Australia 13 377 0.6× 188 0.6× 113 1.0× 91 0.9× 26 0.3× 30 774
Susmeeta T. Sharma United States 16 580 0.9× 265 0.8× 63 0.6× 31 0.3× 35 0.4× 21 775
Katarina Berinder Sweden 12 695 1.0× 262 0.8× 153 1.4× 50 0.5× 42 0.4× 26 868
Ty B Carroll United States 13 545 0.8× 258 0.8× 45 0.4× 53 0.5× 73 0.7× 29 673
Ingrid Ernest Sweden 11 622 0.9× 212 0.7× 80 0.7× 108 1.0× 18 0.2× 17 826
S Zgliczyński Poland 15 501 0.8× 149 0.5× 37 0.3× 53 0.5× 48 0.5× 61 759
WM Drake United Kingdom 10 380 0.6× 114 0.4× 68 0.6× 84 0.8× 36 0.4× 13 576

Countries citing papers authored by Patrick Roger

Since Specialization
Citations

This map shows the geographic impact of Patrick Roger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Roger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Roger more than expected).

Fields of papers citing papers by Patrick Roger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Roger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Roger. The network helps show where Patrick Roger may publish in the future.

Co-authorship network of co-authors of Patrick Roger

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Roger. A scholar is included among the top collaborators of Patrick Roger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Roger. Patrick Roger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gatta, Blandine, Olivier Chabre, Christine Cortet, et al.. (2007). Reevaluation of the Combined Dexamethasone Suppression-Corticotropin-Releasing Hormone Test for Differentiation of Mild Cushing’s Disease from Pseudo-Cushing’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 92(11). 4290–4293. 40 indexed citations
2.
Duclos, Martine, et al.. (2005). Increased Cortisol Bioavailability, Abdominal Obesity, and the Metabolic Syndrome in Obese Women. Obesity Research. 13(7). 1157–1166. 113 indexed citations
3.
Barat, Pascal, Martine Duclos, Blandine Gatta, et al.. (2005). Corticosteroid Binding Globulin Gene Polymorphism Influences Cortisol Driven Fat Distribution in Obese Women. Obesity Research. 13(9). 1485–1490. 25 indexed citations
4.
Salenave, Sylvie, Blandine Gatta, A Visot, et al.. (2004). Pituitary Magnetic Resonance Imaging Findings Do Not Influence Surgical Outcome in Adrenocorticotropin-Secreting Microadenomas. The Journal of Clinical Endocrinology & Metabolism. 89(7). 3371–3376. 82 indexed citations
5.
Catargi, Bogdan, Vincent Rigalleau, V. Vergnot, et al.. (2003). Occult Cushing’s Syndrome in Type-2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 88(12). 5808–5813. 198 indexed citations
6.
Roger, Patrick, et al.. (1999). Addition of Benfluorex to Biguanide Improves Glycemic Control in Obese Non–Insulin-Dependent Diabetes. Journal of Diabetes and its Complications. 13(2). 62–67. 7 indexed citations
7.
Corcuff, Jean‐Benoît, et al.. (1998). Overnight urinary free cortisol determination: A screening test for the diagnosis of Cushing's syndrome. Clinical Endocrinology. 48(4). 503–508. 33 indexed citations
8.
Tabarin, Antoine, François Laurent, Bogdan Catargi, et al.. (1998). Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease. Clinical Endocrinology. 49(3). 293–300. 100 indexed citations
9.
Kraimps, Jean‐Louis, A Denizot, Bruno Carnaille, et al.. (1996). Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type IIa: Retrospective French Multicentric Study. World Journal of Surgery. 20(7). 808–813. 67 indexed citations
10.
Antonelli, Alessandro, et al.. (1994). Pretibial Myxedema and High-Dose Intravenous Immunoglobulin Treatment. Thyroid. 4(4). 399–408. 45 indexed citations
12.
Brue, Thierry, Ioana Lancranjan, Jean‐Pierre Louvet, et al.. (1992). A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study. Fertility and Sterility. 57(1). 74–80. 9 indexed citations
13.
Tabarin, Antoine, et al.. (1992). Plasma concentration of neuropeptide Y in patients with adrenal hypertension. Regulatory Peptides. 42(1-2). 51–61. 15 indexed citations
14.
Tabarin, Antoine, et al.. (1991). Usefulness of the Corticotropin-Releasing Hormone Test during Bilateral Inferior Petrosal Sinus Sampling for the Diagnosis of Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism. 73(1). 53–59. 93 indexed citations
15.
Dufy, B., Patrice Mollard, L. Dufy‐Barbe, et al.. (1988). The Electrophysiological Effects of Thyrotropin-Releasing Hormone Are Similar in Human TSH- and Prolactin-Secreting Pituitary Cells*. The Journal of Clinical Endocrinology & Metabolism. 67(6). 1178–1185. 12 indexed citations
16.
Broustet, A, et al.. (1975). X monosomy and 21 trisomy in a sibship. PubMed. 27(4). 333–337. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026